Apyx Medical (APYX) Free Cash Flow (2011 - 2026)

Apyx Medical has reported Free Cash Flow for 16 years, with the latest figure at -$632000.0 in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 16.51% year-over-year to -$632000.0; the trailing twelve-month figure through Mar 2026 stood at -$9.0 million (up 31.64% YoY), and the FY2025 full-year result was -$9.1 million, up 51.44% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$632000.0, up from -$2.8 million in the prior quarter.
• The five-year high for Free Cash Flow was $3.5 million in Q3 2023, with the low at -$6.4 million in Q1 2024.
• Historically, Free Cash Flow has averaged -$3.3 million across 5 years, with a median of -$4.1 million in 2025.
• Annual changes were most pronounced in 2022 — Free Cash Flow sank 3859.32% — and 2023, when it soared 163.48%.
• Apyx Medical's Free Cash Flow stood at -$4.7 million in 2022, then soared by 50.66% to -$2.3 million in 2023, then tumbled by 38.05% to -$3.2 million in 2024, then gained by 11.88% to -$2.8 million in 2025, then jumped by 77.46% to -$632000.0 in 2026.
• The last three Free Cash Flow figures came in at -$632000.0 (Q1 2026), -$2.8 million (Q4 2025), and -$4.1 million (Q3 2025), per Business Quant data.